×
About 17,703 results

ALLMedicine™ Esophageal Cancer Center

Research & Reviews  5,840 results

Population-Based Cohort Study from a Prospective National Registry: Better Long-Term Su...
https://doi.org/10.1245/s10434-022-11922-5 10.1001/jamaoncol.2019.2996 10.1016/S1470-2045(11)70142-5 10.1056/NEJMoa1112088 10.1097/SLA.0000000000002611 10.1016/S0140-6736(12)60516-9 10.1056/NEJMoa1805101 10.1007/s00268-015-3100-y 10.1097/SLA.0000000000002171 10.1097/SLA.0000000000003031 10.1097/SLA.0000000000003559 10.1200/JCO.19.02483 10.1097/SLA.0b013e31823e39fa 10.1097/SLA.0000000000000644 10.1016/j.athoracsur.2015.09.095 10.1097/SLA.0000000000002393 10.1097/SLA.0000000000003252 10.1097/SLA.0000000000004645 10.1007/s10654-016-0117-y 10.1016/j.ijsu.2014.07.014 10.1002/bjs.10234 10.18637/jss.v045.i03 10.1093/biomet/81.3.515 10.1093/bja/78.2.228-a 10.21037/acs.2017.03.14 10.1245/s10434-014-3873-5 10.1097/SLA.0000000000003500 10.1016/j.athoracsur.2016.02.078 10.1097/SLA.0000000000004708 10.1097/SLA.0000000000003772 10.1097/SLA.0b013e3181bdd5a8 10.1136/bmjopen-2013-004648 10.1007/s00268-013-2233-0 10.1007/s00464-018-6187-z 10.1002/bjs.10577 10.1097/SLA.0000000000002824 10.1093/dote/doy027 10.1177/1457496919826722 10.1056/NEJMsa012337 10.1200/JCO.18.02035 10.1111/dote.12214 10.1097/SLA.0000000000002469 10.1093/annonc/mdw010
Annals of Surgical Oncology; Hayami M, Ndegwa N et. al.

Jun 26th, 2022 - Recent research indicates long-term survival benefits of minimally invasive esophagectomy (MIE) compared with open esophagectomy (OE) for patients with esophageal and gastroesophageal junction (GEJ) cancers, but there is a need for more population...

Comparative effectiveness and stage-shift effect of endoscopic exam among newly diagnos...
https://doi.org/10.1002/hed.27123
Head & Neck; Ho CM, Chen YH et. al.

Jun 26th, 2022 - Patients with oral cancer are at higher risk of developing second primary esophageal cancer (SPEC) and the consensus for screening strategies remains unclear. This study aimed to examine comparative effectiveness and the stage-shift effect of endo...

MAIP1-Related Tumor Immune Infiltration: As a Potential Prognostic Biomarker for Esopha...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213188
Journal of Immunology Research; He X, Gan F et. al.

Jun 25th, 2022 - Esophageal cancer (EC), a common malignant tumor of digestive tract, is also one of the most deadly cancers. Accumulating studies have shown that the initiating and progressing multiple human diseases were closely related to the expression of MAIP...

CT-based radiomics nomogram may predict local recurrence-free survival in esophageal ca...
https://doi.org/10.1016/j.radonc.2022.06.010
Radiotherapy and Oncology : Journal of the European Socie... Gong J, Zhang W et. al.

Jun 25th, 2022 - To establish and validate a contrast-enhanced computed tomography-based hybrid radiomics nomogram for prediction of local recurrence-free survival (LRFS) in esophageal squamous cell cancer (ESCC) patients receiving definitive (chemo)radiotherapy i...

Nutrition Intervention Trials in Linxian Follow-up Study
https://clinicaltrials.gov/ct2/show/NCT00342654

Jun 24th, 2022 - Two large, nutritional intervention trials were conducted in Linxian, China between 1985-1991. These trials tested the effect of multiple vitamins and minerals in the prevention of esophageal cancer in a population with the highest known rate for ...

see more →

Guidelines  10 results

Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Can...
https://doi.org/10.3390/curroncol29050257
Current Oncology (Toronto, Ont.); Mulder K, Lim H et. al.

May 28th, 2022 - Gastric, esophageal and gastro-esophageal junction cancers are associated with inferior outcomes. For early-stage disease, perioperative chemotherapy or chemoradiation followed by surgery is the standard treatment. For most patients with advanced ...

Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline.
https://doi.org/10.1200/JCO.20.00866
Journal of Clinical Oncology : Official Journal of the Am... Shah MA, Kennedy EB et. al.

Jun 23rd, 2020 - To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with locally advanced esophageal cancer. ASCO convened an Expert Panel to conduct a systematic review of the more recently published litera...

Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510875
Esophagus : Official Journal of the Japan Esophageal Soci... Kitagawa Y, Uno T et. al.

Sep 2nd, 2018 -

White Paper AGA: POWER - Practice Guide on Obesity and Weight Management, Education, an...
https://doi.org/10.1016/j.cgh.2016.10.023
Clinical Gastroenterology and Hepatology : the Official C... Acosta A, Streett S et. al.

Mar 1st, 2017 - The epidemic of obesity continues at alarming rates, with a high burden to our economy and society. The American Gastroenterological Association understands the importance of embracing obesity as a chronic, relapsing disease and supports a multidi...

Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137813
Diseases of the Esophagus : Official Journal of the Inter... Rice TW, Ishwaran H et. al.

Dec 3rd, 2016 - We report analytic and consensus processes that produced recommendations for neoadjuvant pathologic stage groups (ypTNM) of esophageal and esophagogastric junction cancer for the AJCC/UICC cancer staging manuals, 8th edition. The Worldwide Esophag...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  772 results

Nutrition Intervention Trials in Linxian Follow-up Study
https://clinicaltrials.gov/ct2/show/NCT00342654

Jun 24th, 2022 - Two large, nutritional intervention trials were conducted in Linxian, China between 1985-1991. These trials tested the effect of multiple vitamins and minerals in the prevention of esophageal cancer in a population with the highest known rate for ...

Early Detection of Esophageal Cancer
https://clinicaltrials.gov/ct2/show/NCT00341523

Jun 24th, 2022 - Esophageal squamous cell carcinoma (ESCC) is a major cause of death in the central Asian esophageal cancer belt and human papillomavirus (HPV) has been proposed as a potential cause. While several HPV-associated cancers have been identified (e.g.,...

Esophageal Cancer Genetics Studies
https://clinicaltrials.gov/ct2/show/NCT00341276

Jun 24th, 2022 - The overall goal of this project is to understand the role of genetics in the etiology and prevention of upper gastrointestinal cancer, primarily esophageal cancer, but also cancers of the gastric cardia and body. Esophageal cancer is the fourth m...

Esophageal Cancer in Northeastern Iran
https://clinicaltrials.gov/ct2/show/NCT00450788

Jun 24th, 2022 - Esophageal cancer is the sixth most common cause of cancer death worldwide, killing over 380,000 people each year. Over 80% of esophageal cancers occur in developing countries, where the great majority of cases are squamous cell carcinomas. Esopha...

Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
https://clinicaltrials.gov/ct2/show/NCT00573131

Jun 22nd, 2022 - The primary objective of this study is to evaluate the efficacy of OncoGel given in combination with standard chemotherapy (cisplatin and 5-FU) and radiation therapy in patients with previously untreated, resectable, local or local-regional adenos...

see more →

News  438 results

Esophageal cancer screening isn’t for everyone: Study
https://www.mdedge.com/internalmedicine/article/255263/gastroenterology/esophageal-cancer-screening-isnt-everyone-study
Brandon May

Jun 7th, 2022 - Endoscopic screening for esophageal adenocarcinoma (EAC), may not be a cost-effective strategy for all populations, possibly even leading to net harm in some, according to a comparative cost-effectiveness analysis. Several U.

Immunotherapy Now First Line for Esophageal Cancer
https://www.medscape.com/viewarticle/974800

May 30th, 2022 - Immunotherapy with nivolumab (Opdivo) is now approved in the United States for first-line use in the treatment of unresectable advanced or metastatic esophageal squamous cell carcinoma (ESCC). The new approval for the drug, a programmed cell death...

Surgery Delay Shortens Survival of Patients With Advanced Esophageal Cancer
https://www.medscape.com/viewarticle/974418

May 24th, 2022 - NEW YORK (Reuters Health) - Delays in surgery for advanced esophageal cancer, such as those implemented in the first months of the COVID-19 pandemic, result in significantly worse outcomes, a new analysis found. Delayed surgery did not appear to a...

Liquid Biopsy Predicts Resistance to Neoadjuvant Therapy in Esophageal Cancer
https://www.medscape.com/viewarticle/974120

May 18th, 2022 - NEW YORK (Reuters Health) - Researchers have developed and validated a liquid biopsy assay that can predict response to neoadjuvant therapy (NAT) in patients with esophageal squamous-cell carcinoma (ESCC), which may lead to more-personalized treat...

Alarming Increase in Esophageal Cancer in Middle-Aged Adults
https://www.medscape.com/viewarticle/974049

May 16th, 2022 - An alarming increase in both esophageal cancer (EC) and the primary precursor lesion for esophageal adenocarcinoma known as Barrett's esophagus (BE) has been observed among middle-aged adults over the past 5 years, and it's not due to better or mo...

see more →

Patient Education  16 results see all →